Health Care

Filter By:



Research Team

Use comma-separated ID numbers for each author

Support the Hoover Institution

Join the Hoover Institution's community of supporters in advancing ideas defining a free society.

Support Hoover

In the News

Health Policy Consensus Group Calls For Short-Term Health Plan Reform

mentioning Lanhee J. Chenvia Mackinac Center for Public Policy (MI)
Wednesday, April 25, 2018

Organizations across the country urge Centers for Medicare and Medicaid Services to make short-term plans renewable

Analysis and Commentary

Viewpoint: Examining The Science Denial Behind IFOAM—Organics International

by Henry I. Miller, Drew L. Kershenvia Genetic Literacy Project
Wednesday, April 25, 2018

The true-believers in organic agriculture, such as the International Federation of Organic Agriculture Movements (IFOAM—Organics International), are as deluded as those who deny the value of vaccines and, like them, have the potential to inflict tremendous harm.

In the News

Fox, Reason, Capitol Hill, And More Outreach Last Week

quoting Henry I. Millervia American Council on Science and Health
Tuesday, April 24, 2018

Henry Miller, MD, and Alex Berezow, PhD, note the uncomfortable truth a whole lot of people attending science march did not want to admit before the second science march - it was first about being against Trump, second about being against Pruitt, third about being against Republicans, and finally about being for the science issues Democrats accept more readily than Republicans. So a whole lot of signs, a whole lot of anti-science environmental groups sponsoring stuff, and hardly a mention of agriculture (except organic food), medicine (except the alternatives to medicine) and no mention at all of energy.


Scott Atlas On The Lars Larson National Podcast (1:29:50)

interview with Scott W. Atlasvia Lars Larson National Podcast
Friday, April 20, 2018

Hoover Institution fellow Scott Atlas discusses how to fix the high cost of medications by exposing the cost of medications to competition and value seeking purchasers.


Lanhee Chen On The Lars Larson National Podcast (50:45)

interview with Lanhee J. Chenvia Lars Larson National Podcast
Tuesday, April 17, 2018

Hoover Institution fellow Lanhee Chen discusses health care and how to give states the authority to craft solutions that meet the needs of their residents.


Scott Atlas: Moderating Big Pharma Prices While Maintaining The Genius

interview with Scott W. Atlasvia The John Batchelor Show
Wednesday, April 11, 2018

Hoover Institution fellow Scott Atlas discusses his Defining Ideas column "An Overlooked Key To Lower Drug Prices."

Analysis and Commentary

Vincent Rajkumar On The High Price Of Cancer Drugs

by Russell Robertsvia EconTalk
Monday, April 9, 2018

Can a life-saving drug be too expensive? What explains the high price of cancer drugs? Dr. Vincent Rajkumar of the Mayo Clinic talks with EconTalk host Russ Roberts about the high price of cancer drugs--drugs that can cost an American with cancer $300,000 per year and require multiple years of treatment.

In the News

5 Stunning Facts About World Health

quoting John Villasenorvia Brookings Institution
Friday, April 6, 2018

April 7 is World Health Day, a day designated by the World Health Organization to promote health for all people across the globe. This is a serious issue facing the international community. Half of the world’s population lacks access to vital health services and over a hundred million people worldwide have been pushed into poverty due to high health care costs.

Analysis and Commentary

Cannon On How To Fix Obamacare

by David R. Hendersonvia EconLog
Thursday, April 5, 2018

Health care economist John C. Goodman once asked a great question in his discussion of health insurance regulation and Obamacare: "Would you want to eat at a restaurant that doesn't want you as a customer?" John applied that to proposals to require a combination of guaranteed issue and a ban on pricing for pre-existing conditions. The two are both major parts of Obamacare.

Blank Section (Placeholder)Featured

An Overlooked Key To Lower Drug Prices

by Scott W. Atlasvia Defining Ideas
Wednesday, April 4, 2018

Policies aimed at reducing costs must not restrict supply, jeopardize quality, or inhibit innovation.


Health Care Policy Working Group

The Working Group on Health Care Policy devises public policies that enable more Americans to get better value for their health care dollar and foster appropriate innovations that will extend and improve life.